Regucalcin (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Regucalcin" in English language version.

refsWebsite

Global rank English rank

24nih.gov

4^th place

20doi.org

2^nd place

8semanticscholar.org

11^th place

8^th place

2ensembl.org

1,626^th place

1,007^th place

1handle.net

102^nd place

76^th place

doi.org

Shimokawa N, Matsuda Y, Yamaguchi M (October 1995). "Genomic cloning and chromosomal assignment of rat regucalcin gene". Molecular and Cellular Biochemistry. 151 (2): 157–63. doi:10.1007/BF01322338. PMID 8569761. S2CID 20648596.
Fujita T, Mandel JL, Shirasawa T, Hino O, Shirai T, Maruyama N (September 1995). "Isolation of cDNA clone encoding human homologue of senescence marker protein-30 (SMP30) and its location on the X chromosome". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1263 (3): 249–52. doi:10.1016/0167-4781(95)00120-6. PMID 7548213.
Yamaguchi M, Isogai M, Kato S, Mori S (June 1991). "Immunohistochemical demonstration of calcium-binding protein regucalcin in the tissues of rats: the protein localizes in liver and brain". Chemical & Pharmaceutical Bulletin. 39 (6): 1601–3. doi:10.1248/cpb.39.1601. PMID 1934180.
Shimokawa N, Yamaguchi M (June 1992). "Calcium administration stimulates the expression of calcium-binding protein regucalcin mRNA in rat liver". FEBS Letters. 305 (2): 151–4. doi:10.1016/0014-5793(92)80884-J. PMID 1618342. S2CID 24974683.
Yamaguchi M, Isogai M (May 1993). "Tissue concentration of calcium-binding protein regucalcin in rats by enzyme-linked immunoadsorbent assay". Molecular and Cellular Biochemistry. 122 (1): 65–8. doi:10.1007/BF00925738. PMID 8350865. S2CID 22140722.
Misawa H, Yamaguchi M (August 2000). "The gene of Ca2+-binding protein regucalcin is highly conserved in vertebrate species". International Journal of Molecular Medicine. 6 (2): 191–6. doi:10.3892/ijmm.6.2.191. PMID 10891565.
Yamaguchi M, Yamamoto T (June 1978). "Purification of calcium binding substance from soluble fraction of normal rat liver". Chemical & Pharmaceutical Bulletin. 26 (6): 1915–8. doi:10.1248/cpb.26.1915. PMID 699201.
Yamaguchi M, Sugii K (February 1981). "Properties of calcium-binding protein isolated from the soluble fraction of normal rat liver". Chemical & Pharmaceutical Bulletin. 29 (2): 567–70. doi:10.1248/cpb.29.567. PMID 7273253.
Yamaguchi M, Mori S (January 1988). "Effect of Ca2+ and Zn2+ on 5'-nucleotidase activity in rat liver plasma membranes: Hepatic calcium-binding protein (regucalcin) reverses the Ca2+ effect". Chemical & Pharmaceutical Bulletin. 36 (1): 321–325. doi:10.1248/cpb.36.321. PMID 2837338.
Fujita T, Uchida K, Maruyama N (April 1992). "Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver". Biochimica et Biophysica Acta (BBA) - General Subjects. 1116 (2): 122–8. doi:10.1016/0304-4165(92)90108-7. PMID 1581340.
Fujita T, Shirasawa T, Uchida K, Maruyama N (October 1992). "Isolation of cDNA clone encoding rat senescence marker protein-30 (SMP30) and its tissue distribution". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1132 (3): 297–305. doi:10.1016/0167-4781(92)90164-u. PMID 1420310.
Shimokawa N, Yamaguchi M (August 1993). "Molecular cloning and sequencing of the cDNA coding for a calcium-binding protein regucalcin from rat liver". FEBS Letters. 327 (3): 251–5. doi:10.1016/0014-5793(93)80998-a. PMID 8348951. S2CID 1303220.
Yamaguchi M, Makino R, Shimokawa N (December 1996). "The 5' end sequences and exon organization in rat regucalcin gene". Molecular and Cellular Biochemistry. 165 (2): 145–50. doi:10.1007/bf00229476. PMID 8979263. S2CID 10508949.
Yamaguchi M (January 2011). "The transcriptional regulation of regucalcin gene expression". Molecular and Cellular Biochemistry. 346 (1–2): 147–71. doi:10.1007/s11010-010-0601-8. PMID 20936536. S2CID 22077914.
Yamaguchi M (March 2005). "Role of regucalcin in maintaining cell homeostasis and function (review)". International Journal of Molecular Medicine. 15 (3): 371–89. doi:10.3892/ijmm.15.3.371. PMID 15702226.
Yamaguchi M (August 2010). "Regucalcin and metabolic disorders: osteoporosis and hyperlipidemia are induced in regucalcin transgenic rats". Molecular and Cellular Biochemistry. 341 (1–2): 119–33. doi:10.1007/s11010-010-0443-4. PMID 20349117. S2CID 12577305.
Yamaguchi M (August 2015). "Involvement of regucalcin as a suppressor protein in human carcinogenesis: Insight into the gene therapy". Journal of Cancer Research and Clinical Oncology. 141 (8): 133–1341. doi:10.1007/s00432-014-1831-z. PMID 25230901. S2CID 25371567.
Yamaguchi M, Osuka S, Weitzmann MN, El-Rayes BF, Shoji M, Murata T (May 2016). "Prolonged survival in pancreatic cancer patients with increased regucalcin gene expression: Overexpression of regucalcin suppresses the proliferation in human pancreatic cancer MIA PaCa-2 cells in vitro". International Journal of Oncology. 48 (5): 1955–1964. doi:10.3892/ijo.2016.3409. PMID 26935290.
Cardosoa AL, Fernandes A, Aguilar-Pimentelc JA, de Angelisd MH, Guedes JR, Britob MA, Ortolano S, Pani G, Athanasopoulou S, Gonos ES, Schosserer M, Grillari J, Peterson P, Tuna BG, Dogan S, Meyer A, van Os R, Trendelenburg AU (July 2018). "Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases". Journal of Cancer Research and Clinical Oncology. 47: 214–277. doi:10.1016/j.arr.2018.07.004. hdl:10807/130553. PMID 30071357.
Nitschkowski D, Marwitz S, Kotanidou SA, Reck M, Kugler C, Rabe KF, Ammerpohl O, Goldmann T (November 2019). "Live and let die: epigenetic modifications of Survivin and Regucalcin in non-small cell lung cancer tissues contribute to malignancy". Clinical Epigenetics. 11 (1): 157. doi:10.1186/s13148-019-0770-6. PMC 6852724. PMID 31718698.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000130988 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000023070 – Ensembl, May 2017

handle.net

hdl.handle.net

Cardosoa AL, Fernandes A, Aguilar-Pimentelc JA, de Angelisd MH, Guedes JR, Britob MA, Ortolano S, Pani G, Athanasopoulou S, Gonos ES, Schosserer M, Grillari J, Peterson P, Tuna BG, Dogan S, Meyer A, van Os R, Trendelenburg AU (July 2018). "Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases". Journal of Cancer Research and Clinical Oncology. 47: 214–277. doi:10.1016/j.arr.2018.07.004. hdl:10807/130553. PMID 30071357.

nih.gov

pubmed.ncbi.nlm.nih.gov

Shimokawa N, Matsuda Y, Yamaguchi M (October 1995). "Genomic cloning and chromosomal assignment of rat regucalcin gene". Molecular and Cellular Biochemistry. 151 (2): 157–63. doi:10.1007/BF01322338. PMID 8569761. S2CID 20648596.
Fujita T, Mandel JL, Shirasawa T, Hino O, Shirai T, Maruyama N (September 1995). "Isolation of cDNA clone encoding human homologue of senescence marker protein-30 (SMP30) and its location on the X chromosome". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1263 (3): 249–52. doi:10.1016/0167-4781(95)00120-6. PMID 7548213.
Yamaguchi M, Isogai M, Kato S, Mori S (June 1991). "Immunohistochemical demonstration of calcium-binding protein regucalcin in the tissues of rats: the protein localizes in liver and brain". Chemical & Pharmaceutical Bulletin. 39 (6): 1601–3. doi:10.1248/cpb.39.1601. PMID 1934180.
Shimokawa N, Yamaguchi M (June 1992). "Calcium administration stimulates the expression of calcium-binding protein regucalcin mRNA in rat liver". FEBS Letters. 305 (2): 151–4. doi:10.1016/0014-5793(92)80884-J. PMID 1618342. S2CID 24974683.
Yamaguchi M, Isogai M (May 1993). "Tissue concentration of calcium-binding protein regucalcin in rats by enzyme-linked immunoadsorbent assay". Molecular and Cellular Biochemistry. 122 (1): 65–8. doi:10.1007/BF00925738. PMID 8350865. S2CID 22140722.
Misawa H, Yamaguchi M (August 2000). "The gene of Ca2+-binding protein regucalcin is highly conserved in vertebrate species". International Journal of Molecular Medicine. 6 (2): 191–6. doi:10.3892/ijmm.6.2.191. PMID 10891565.
Yamaguchi M, Yamamoto T (June 1978). "Purification of calcium binding substance from soluble fraction of normal rat liver". Chemical & Pharmaceutical Bulletin. 26 (6): 1915–8. doi:10.1248/cpb.26.1915. PMID 699201.
Yamaguchi M, Sugii K (February 1981). "Properties of calcium-binding protein isolated from the soluble fraction of normal rat liver". Chemical & Pharmaceutical Bulletin. 29 (2): 567–70. doi:10.1248/cpb.29.567. PMID 7273253.
Yamaguchi M, Mori S (January 1988). "Effect of Ca2+ and Zn2+ on 5'-nucleotidase activity in rat liver plasma membranes: Hepatic calcium-binding protein (regucalcin) reverses the Ca2+ effect". Chemical & Pharmaceutical Bulletin. 36 (1): 321–325. doi:10.1248/cpb.36.321. PMID 2837338.
Fujita T, Uchida K, Maruyama N (April 1992). "Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver". Biochimica et Biophysica Acta (BBA) - General Subjects. 1116 (2): 122–8. doi:10.1016/0304-4165(92)90108-7. PMID 1581340.
Fujita T, Shirasawa T, Uchida K, Maruyama N (October 1992). "Isolation of cDNA clone encoding rat senescence marker protein-30 (SMP30) and its tissue distribution". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1132 (3): 297–305. doi:10.1016/0167-4781(92)90164-u. PMID 1420310.
Shimokawa N, Yamaguchi M (August 1993). "Molecular cloning and sequencing of the cDNA coding for a calcium-binding protein regucalcin from rat liver". FEBS Letters. 327 (3): 251–5. doi:10.1016/0014-5793(93)80998-a. PMID 8348951. S2CID 1303220.
Yamaguchi M, Makino R, Shimokawa N (December 1996). "The 5' end sequences and exon organization in rat regucalcin gene". Molecular and Cellular Biochemistry. 165 (2): 145–50. doi:10.1007/bf00229476. PMID 8979263. S2CID 10508949.
Yamaguchi M (January 2011). "The transcriptional regulation of regucalcin gene expression". Molecular and Cellular Biochemistry. 346 (1–2): 147–71. doi:10.1007/s11010-010-0601-8. PMID 20936536. S2CID 22077914.
Yamaguchi M (March 2005). "Role of regucalcin in maintaining cell homeostasis and function (review)". International Journal of Molecular Medicine. 15 (3): 371–89. doi:10.3892/ijmm.15.3.371. PMID 15702226.
Yamaguchi M (August 2010). "Regucalcin and metabolic disorders: osteoporosis and hyperlipidemia are induced in regucalcin transgenic rats". Molecular and Cellular Biochemistry. 341 (1–2): 119–33. doi:10.1007/s11010-010-0443-4. PMID 20349117. S2CID 12577305.
Yamaguchi M (August 2015). "Involvement of regucalcin as a suppressor protein in human carcinogenesis: Insight into the gene therapy". Journal of Cancer Research and Clinical Oncology. 141 (8): 133–1341. doi:10.1007/s00432-014-1831-z. PMID 25230901. S2CID 25371567.
Yamaguchi M, Osuka S, Weitzmann MN, El-Rayes BF, Shoji M, Murata T (May 2016). "Prolonged survival in pancreatic cancer patients with increased regucalcin gene expression: Overexpression of regucalcin suppresses the proliferation in human pancreatic cancer MIA PaCa-2 cells in vitro". International Journal of Oncology. 48 (5): 1955–1964. doi:10.3892/ijo.2016.3409. PMID 26935290.
Cardosoa AL, Fernandes A, Aguilar-Pimentelc JA, de Angelisd MH, Guedes JR, Britob MA, Ortolano S, Pani G, Athanasopoulou S, Gonos ES, Schosserer M, Grillari J, Peterson P, Tuna BG, Dogan S, Meyer A, van Os R, Trendelenburg AU (July 2018). "Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases". Journal of Cancer Research and Clinical Oncology. 47: 214–277. doi:10.1016/j.arr.2018.07.004. hdl:10807/130553. PMID 30071357.
Nitschkowski D, Marwitz S, Kotanidou SA, Reck M, Kugler C, Rabe KF, Ammerpohl O, Goldmann T (November 2019). "Live and let die: epigenetic modifications of Survivin and Regucalcin in non-small cell lung cancer tissues contribute to malignancy". Clinical Epigenetics. 11 (1): 157. doi:10.1186/s13148-019-0770-6. PMC 6852724. PMID 31718698.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: RGN regucalcin (senescence marker protein-30)".
Nitschkowski D, Marwitz S, Kotanidou SA, Reck M, Kugler C, Rabe KF, Ammerpohl O, Goldmann T (November 2019). "Live and let die: epigenetic modifications of Survivin and Regucalcin in non-small cell lung cancer tissues contribute to malignancy". Clinical Epigenetics. 11 (1): 157. doi:10.1186/s13148-019-0770-6. PMC 6852724. PMID 31718698.

semanticscholar.org

api.semanticscholar.org

Shimokawa N, Matsuda Y, Yamaguchi M (October 1995). "Genomic cloning and chromosomal assignment of rat regucalcin gene". Molecular and Cellular Biochemistry. 151 (2): 157–63. doi:10.1007/BF01322338. PMID 8569761. S2CID 20648596.
Shimokawa N, Yamaguchi M (June 1992). "Calcium administration stimulates the expression of calcium-binding protein regucalcin mRNA in rat liver". FEBS Letters. 305 (2): 151–4. doi:10.1016/0014-5793(92)80884-J. PMID 1618342. S2CID 24974683.
Yamaguchi M, Isogai M (May 1993). "Tissue concentration of calcium-binding protein regucalcin in rats by enzyme-linked immunoadsorbent assay". Molecular and Cellular Biochemistry. 122 (1): 65–8. doi:10.1007/BF00925738. PMID 8350865. S2CID 22140722.
Shimokawa N, Yamaguchi M (August 1993). "Molecular cloning and sequencing of the cDNA coding for a calcium-binding protein regucalcin from rat liver". FEBS Letters. 327 (3): 251–5. doi:10.1016/0014-5793(93)80998-a. PMID 8348951. S2CID 1303220.
Yamaguchi M, Makino R, Shimokawa N (December 1996). "The 5' end sequences and exon organization in rat regucalcin gene". Molecular and Cellular Biochemistry. 165 (2): 145–50. doi:10.1007/bf00229476. PMID 8979263. S2CID 10508949.
Yamaguchi M (January 2011). "The transcriptional regulation of regucalcin gene expression". Molecular and Cellular Biochemistry. 346 (1–2): 147–71. doi:10.1007/s11010-010-0601-8. PMID 20936536. S2CID 22077914.
Yamaguchi M (August 2010). "Regucalcin and metabolic disorders: osteoporosis and hyperlipidemia are induced in regucalcin transgenic rats". Molecular and Cellular Biochemistry. 341 (1–2): 119–33. doi:10.1007/s11010-010-0443-4. PMID 20349117. S2CID 12577305.
Yamaguchi M (August 2015). "Involvement of regucalcin as a suppressor protein in human carcinogenesis: Insight into the gene therapy". Journal of Cancer Research and Clinical Oncology. 141 (8): 133–1341. doi:10.1007/s00432-014-1831-z. PMID 25230901. S2CID 25371567.